3′LIFE: a functional assay to detect miRNA targets in high-throughput
暂无分享,去创建一个
Mari Firago | Marco Mangone | M. Mangone | J. Wolter | Justin M. Wolter | Kasuen Kotagama | Alexandra C. Pierre-Bez | Kasuen Kotagama | Alexandra C Pierre-Bez | Mari Firago | Marco Mangone | Mari Firago
[1] S. Lindquist,et al. Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. , 2012, The Journal of clinical investigation.
[2] R. Kalluri,et al. Methylation determines fibroblast activation and fibrogenesis in the kidney , 2010, Nature Medicine.
[3] G. Mufti,et al. A functional assay for microRNA target identification and validation , 2010, Nucleic acids research.
[4] A. Lund,et al. The miR-10 microRNA precursor family , 2011, RNA biology.
[5] Rodrigo Lopez,et al. Clustal W and Clustal X version 2.0 , 2007, Bioinform..
[6] R. Birge,et al. Crk at the Quarter Century Mark: Perspectives in Signaling and Cancer , 2014, Journal of cellular biochemistry.
[7] Z. Songyang,et al. Large-Scale Screens of miRNA-mRNA Interactions Unveiled That the 3′UTR of a Gene Is Targeted by Multiple miRNAs , 2013, PloS one.
[8] S. Matsuda,et al. Suppression of cell spreading by v-Crk requires Ras-MEK-MAP kinase signaling , 2001, Oncogene.
[9] P. Goyette,et al. RARgamma acts as a tumor suppressor in mouse keratinocytes. , 2004, Oncogene.
[10] G. Daley,et al. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence , 2002, Nature Cell Biology.
[11] N. Reyhani,et al. Cancer-Predicting Gene Expression Changes in Colonic Mucosa of Western Diet Fed Mlh1 +/- Mice , 2013, PloS one.
[12] Daoud Meerzaman,et al. SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells. , 2008, Cancer research.
[13] J. Gu,et al. Let‐7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer , 2012, The Journal of pathology.
[14] K. Ohuchida,et al. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. , 2011, Surgery.
[15] Jeffrey E. Green,et al. Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß , 2013, PloS one.
[16] J. Bharti,et al. Evaluation of p53, HoxD10, and E-Cadherin Status in Breast Cancer and Correlation with Histological Grade and Other Prognostic Factors , 2014, Journal of oncology.
[17] Yali Dou,et al. Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases , 2006, Proceedings of the National Academy of Sciences.
[18] M. Shirane,et al. Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome , 2009, British Journal of Cancer.
[19] M. Hallett,et al. Stromal retinoic acid receptor β promotes mammary gland tumorigenesis , 2010, Proceedings of the National Academy of Sciences.
[20] Wei Li,et al. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression , 2014, Nature.
[21] Zuoshang Xu,et al. A construct with fluorescent indicators for conditional expression of miRNA , 2008, BMC biotechnology.
[22] Bryan R. Cullen,et al. MicroRNA Target Site Identification by Integrating Sequence and Binding Information , 2013, Nature Methods.
[23] Michael Rehli,et al. Genome‐wide methylation screen in low‐grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] Pierre Validire,et al. Integrated molecular portrait of non-small cell lung cancers , 2013, BMC Medical Genomics.
[25] Chi-Ying F. Huang,et al. miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..
[26] P. Dollé,et al. Retinoic acid in development: towards an integrated view , 2008, Nature Reviews Genetics.
[27] E. S. Yang,et al. RNA interference targeting sensitive-to-apoptosis gene potentiates doxorubicin- and staurosporine-induced apoptosis of PC3 cells. , 2013, Anticancer research.
[28] H. Friess,et al. Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. , 1999, Biochemical and biophysical research communications.
[29] W. V. van IJcken,et al. CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer , 2009, British Journal of Cancer.
[30] Angela M. Liu,et al. Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122* , 2011, The Journal of Biological Chemistry.
[31] Eugene Berezikov,et al. Evolution of microRNA diversity and regulation in animals , 2011, Nature Reviews Genetics.
[32] Jianying Bai,et al. Ascl2 Knockdown Results in Tumor Growth Arrest by miRNA-302b-Related Inhibition of Colon Cancer Progenitor Cells , 2012, PloS one.
[33] H. Drexler,et al. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. , 2010, Leukemia research.
[34] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[35] T. Golde,et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor , 2008, Oncogene.
[36] M. Privalsky,et al. Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation , 2011, Molecular and Cellular Endocrinology.
[37] Kerstin B. Meyer,et al. Master regulators of FGFR2 signalling and breast cancer risk , 2013, Nature Communications.
[38] W. Tan,et al. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. , 2011, Cancer research.
[39] D. Moskophidis,et al. Heat Shock Factor Hsf1 Cooperates with ErbB2 (Her2/Neu) Protein to Promote Mammary Tumorigenesis and Metastasis* , 2012, The Journal of Biological Chemistry.
[40] Yi Li,et al. Loss of GATA3 in bladder cancer promotes cell migration and invasion , 2014, Cancer biology & therapy.
[41] G. Sauvageau,et al. EN2 is a candidate oncogene in human breast cancer , 2005, Oncogene.
[42] Shiaw-Yih Lin,et al. Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs. , 2013, Cancer research.
[43] C. Mayr,et al. Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.
[44] P. Goyette,et al. RARγ acts as a tumor suppressor in mouse keratinocytes , 2004, Oncogene.
[45] M. Tsuda,et al. Roles for crk in cancer metastasis and invasion. , 2012, Genes & cancer.
[46] J. Manley,et al. RNA recognition by the human polyadenylation factor CstF , 1997, Molecular and cellular biology.
[47] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[48] M. Chou,et al. Atypical Mechanism of NF-κB activation by TRE17/Ubiquitin-Specific Protease 6 (USP6) oncogene and its requirement in tumorigenesis , 2011, Oncogene.
[49] Y. Mo,et al. Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer , 2013, Oncogene.
[50] M. Lerch,et al. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. , 2009, Gastroenterology.
[51] Robert Gentleman,et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.
[52] R. Merrill,et al. All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos , 2004, Biological chemistry.
[53] Zhihua Liu,et al. MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines* , 2010, The Journal of Biological Chemistry.
[54] Peter J. Shepard,et al. Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. , 2011, RNA.
[55] Chung-I Wu,et al. The evolution of evolvability in microRNA target sites in vertebrates , 2013, Genome research.
[56] Yi Zheng,et al. A distinct role of RhoB in gastric cancer suppression , 2011, International journal of cancer.
[57] A. Chase,et al. Aberrations of EZH2 in Cancer , 2011, Clinical Cancer Research.
[58] R. Stallings,et al. MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2 , 2011, Cell Death and Differentiation.
[59] R. Benezra,et al. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras. , 2005, Cancer research.
[60] Scott B. Dewell,et al. Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.
[61] R. Schiff,et al. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells. , 2013, Cancer cell.
[62] I. Bleiweiss,et al. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[63] Amit Sharma,et al. DNASU plasmid and PSI:Biology-Materials repositories: resources to accelerate biological research , 2013, Nucleic Acids Res..
[64] A. Giaccia,et al. Mitogen-activated protein kinase acts as a negative regulator of the heat shock response in NIH3T3 cells. , 1995, Cancer research.
[65] A. Toker,et al. RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. , 2013, Cancer research.
[66] M. Hanna,et al. Biodiesel production : a review , 1999 .
[67] M. J. van de Vijver,et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. , 2011, Cell stem cell.
[68] Michael R. Green,et al. Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors , 2013, Genes & development.
[69] Zhiyuan Shen,et al. BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage , 2007, Nucleic acids research.
[70] W. Filipowicz,et al. Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress , 2006, Cell.
[71] G. Crooks,et al. WebLogo: a sequence logo generator. , 2004, Genome research.
[72] M. Esteller,et al. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis , 2013, Oncogene.
[73] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[74] A. Ross,et al. Retinoic acid and α-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation. , 2013, Immunobiology.
[75] Hua Yu,et al. The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.
[76] Xin Fu,et al. Analysis of genetic aberrations on chromosomal region 8q21–24 identifies E2F5 as an oncogene with copy number gain in prostate cancer , 2013, Medical Oncology.
[77] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[78] H. Noh,et al. p53 down-regulates SETDB1 gene expression during paclitaxel induced-cell death. , 2014, Biochemical and biophysical research communications.
[79] Hao Wang,et al. Normal prostate‐derived stromal cells stimulate prostate cancer development , 2011, Cancer science.
[80] M. Emmert-Buck,et al. Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer. , 2013, The American journal of pathology.
[81] M. Resh,et al. Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma , 2014, Oncogene.
[82] J. Kitzman,et al. Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. , 2007, RNA.
[83] C. Brenner,et al. RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis , 2014, Oncogene.
[84] Takashi Suzuki,et al. LIN28: A regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer , 2012, The Journal of Steroid Biochemistry and Molecular Biology.
[85] E. Gabrielson,et al. Frequent down-regulation of HIVEP2 in human breast cancer , 2005, Breast Cancer Research and Treatment.
[86] R Tibshirani,et al. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification , 2006, Oncogene.
[87] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[88] A. Ochiai,et al. RAS oncogenic signal upregulates EZH2 in pancreatic cancer. , 2012, Biochemical and biophysical research communications.
[89] G. Wong,et al. Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion* , 2010, The Journal of Biological Chemistry.
[90] Nectarios Koziris,et al. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support , 2011, Nucleic Acids Res..
[91] A. Ridley. RhoA, RhoB and RhoC have different roles in cancer cell migration , 2013, Journal of microscopy.
[92] Edward W. Tate,et al. Attenuation of Hedgehog Acyltransferase-Catalyzed Sonic Hedgehog Palmitoylation Causes Reduced Signaling, Proliferation and Invasiveness of Human Carcinoma Cells , 2014, PloS one.
[93] B. Mankoo,et al. Retinoic acid is both necessary for and inhibits myogenic commitment and differentiation in the chick limb. , 2010, The International journal of developmental biology.
[94] Y. Mo,et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. , 2008, Cancer research.
[95] V. Jordan,et al. Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells , 2010, Hormone molecular biology and clinical investigation.
[96] Min Jung Park,et al. Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation. , 2003, Molecular cancer research : MCR.
[97] Martin Reczko,et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..
[98] Kendall W. Cradic,et al. Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target. , 2010, The Journal of clinical endocrinology and metabolism.
[99] B. Barlogie,et al. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. , 2007, Blood.
[100] Yusuke Nakamura,et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population , 2010, Nature Genetics.
[101] N. Rajewsky,et al. The evolution of gene regulation by transcription factors and microRNAs , 2007, Nature Reviews Genetics.
[102] F. Zhan,et al. RARα2 expression confers myeloma stem cell features. , 2013, Blood.
[103] Robert A. Weinberg,et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.
[104] N. Rajewsky,et al. Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.
[105] P. Meltzer,et al. Activating Signal Cointegrator 2 Belongs to a Novel Steady-State Complex That Contains a Subset of Trithorax Group Proteins , 2003, Molecular and Cellular Biology.
[106] R. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.
[107] Ligang Wu,et al. Micro-RNA Regulation of the Mammalian lin-28 Gene during Neuronal Differentiation of Embryonal Carcinoma Cells , 2005, Molecular and Cellular Biology.
[108] M. Stoffel,et al. MicroRNA-96 Directly Inhibits γ-Globin Expression in Human Erythropoiesis , 2011, PloS one.
[109] Bruce T. Lahn,et al. Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter , 2010, PloS one.
[110] K. White,et al. Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer , 2009, Cell.
[111] T. Sugimura,et al. Identification of 20 genes aberrantly methylated in human breast cancers , 2005, International journal of cancer.
[112] Z. Werb,et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression , 2013, Nature Cell Biology.
[113] H. Feilotter,et al. miR-193b Regulates Mcl-1 in Melanoma. , 2011, The American journal of pathology.
[114] George Easow,et al. Isolation of microRNA targets by miRNP immunopurification. , 2007, RNA.
[115] K. Ross,et al. Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors , 2010, PloS one.
[116] R. Rodriguez,et al. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. , 2000, Analytical biochemistry.
[117] C. Litterst,et al. Transcriptional Activation by STAT6 Requires the Direct Interaction with NCoA-1* , 2001, The Journal of Biological Chemistry.
[118] Margaret S. Ebert,et al. Roles for MicroRNAs in Conferring Robustness to Biological Processes , 2012, Cell.
[119] Michael R. Green,et al. An elaborate pathway required for Ras-mediated epigenetic silencing , 2007, Nature.
[120] A. Clarke,et al. Entopic overexpression of Ascl2 does not accelerate tumourigenesis in ApcMin mice , 2011, Gut.
[121] Guan Sun,et al. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10 , 2011, Brain Research.
[122] W. Grizzle,et al. Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer. , 2013, American journal of clinical pathology.
[123] E. Flemington,et al. MicroRNA miR-155 Inhibits Bone Morphogenetic Protein (BMP) Signaling and BMP-Mediated Epstein-Barr Virus Reactivation , 2010, Journal of Virology.
[124] Anna M. Krichevsky,et al. Context effect: microRNA-10b in cancer cell proliferation, spread and death , 2011, Autophagy.
[125] H. Guan,et al. Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model , 2013, BMC Cancer.
[126] W. Gerald,et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen , 2006, Oncogene.
[127] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[128] K. Pollard,et al. Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.
[129] T. Pandita,et al. E2FBP1 antagonizes the p16INK4A-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability , 2011, International Journal of Oral Science.
[130] E. Kistner,et al. Let-7 expression defines two differentiation stages of cancer , 2007, Proceedings of the National Academy of Sciences.
[131] M. Raffeld,et al. ANXA7 expression represents hormone‐relevant tumor suppression in different cancers , 2007, International journal of cancer.
[132] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[133] Nicolás Peláez,et al. Biological robustness and the role of microRNAs: a network perspective. , 2012, Current topics in developmental biology.
[134] Sebastian D. Mackowiak,et al. The Landscape of C. elegans 3′UTRs , 2010, Science.
[135] Michael J. Terry,et al. HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas , 2002, Oncogene.
[136] A. Svindland,et al. Regulation of PBX3 expression by androgen and Let-7d in prostate cancer , 2011, Molecular Cancer.
[137] V. Thakur,et al. Multifaceted role of EZH2 in breast and prostate tumorigenesis , 2013, Epigenetics.
[138] H. Salih,et al. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA , 2006, Cancer Immunology, Immunotherapy.
[139] E. Paltrinieri,et al. let-7 and miR-140 microRNAs coordinately regulate skeletal development , 2013, Proceedings of the National Academy of Sciences.
[140] D. Bartel,et al. The impact of microRNAs on protein output , 2008, Nature.
[141] D. Yee,et al. STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. , 2002, Neoplasia.
[142] S. Chi,et al. An alternative mode of microRNA target recognition , 2012, Nature Structural &Molecular Biology.
[143] Patrice M. Milos,et al. An in-depth map of polyadenylation sites in cancer , 2012, Nucleic acids research.
[144] S. Filetti,et al. Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. , 2012, Thyroid : official journal of the American Thyroid Association.
[145] Tanya Stoyanova,et al. Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer. , 2012, Cancer research.
[146] M. Campbell,et al. Transcription factor co‐repressors in cancer biology: roles and targeting , 2010, International journal of cancer.
[147] T. Khoury,et al. Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer , 2013, Oncotarget.
[148] Deepa Subramanyam,et al. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis , 2009, Molecular Cancer.
[149] S. Lindquist,et al. Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis , 2007, Cell.
[150] M. Washington,et al. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity. , 2013, Gastroenterology.
[151] N. Xi,et al. Inactivation of SAG E3 Ubiquitin Ligase Blocks Embryonic Stem Cell Differentiation and Sensitizes Leukemia Cells to Retinoid Acid , 2011, PloS one.
[152] C. Croce,et al. Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.
[153] N. Tsuji,et al. Specific overexpression of OLFM4GW112/hGC−1 mRNA in colon, breast and lung cancer tissues detected using quantitative analysis , 2007, Cancer science.
[154] 张伟,et al. Oncogenic Activity of Retinoic Acid Receptor gamma Is Exhibited through Activation of the Akt/NF-kappa B and Wnt/beta-Catenin Pathways in Cholangiocarcinoma , 2013 .
[155] Gideon Rechavi,et al. Gene expression regulation mediated through reversible m6A RNA methylation , 2014, Nature Reviews Genetics.
[156] G. Bepler,et al. ID1 Facilitates the Growth and Metastasis of Non-Small Cell Lung Cancer in Response to Nicotinic Acetylcholine Receptor and Epidermal Growth Factor Receptor Signaling , 2011, Molecular and Cellular Biology.
[157] R. Kramer,et al. Sdc1 negatively modulates carcinoma cell motility and invasion. , 2010, Experimental cell research.
[158] F. Slack,et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.
[159] Kyle Kai-How Farh,et al. Expanding the microRNA targeting code: functional sites with centered pairing. , 2010, Molecular cell.
[160] Geoffrey Childs,et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. , 2009, The American journal of pathology.
[161] N. Hayashi,et al. Serum levels of soluble major histocompatibility complex (MHC) class I‐related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma , 2008, Cancer science.
[162] J. Bishop,et al. Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response , 2008, Proceedings of the National Academy of Sciences.
[163] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[164] A. Graybiel,et al. Crk Activation of JNK via C3G and R-Ras* , 2000, The Journal of Biological Chemistry.
[165] Yingyan Yu,et al. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone , 2014, BMC Cancer.
[166] D. Fisher,et al. Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene carbohydrate sulfotransferase 10. , 2009, Cancer research.
[167] C. Molina,et al. Ras‐induced melanoma transformation is associated with the proteasomal degradation of the transcriptional repressor ICER , 2013, Molecular carcinogenesis.
[168] J. Rutka,et al. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I. , 2010, Molecular cell.
[169] D. Tollervey,et al. Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding , 2013, Cell.
[170] T. Eberlein,et al. Specific Activation of Retinoic Acid Receptors (RARs) and Retinoid X Receptors Reveals a Unique Role for RARγ in Induction of Differentiation and Apoptosis of S91 Melanoma Cells* , 1997, The Journal of Biological Chemistry.
[171] Yunhong Zha,et al. Functional Dissection of HOXD Cluster Genes in Regulation of Neuroblastoma Cell Proliferation and Differentiation , 2012, PloS one.
[172] Junjiang Fu,et al. DLX4 Upregulates TWIST and Enhances Tumor Migration, Invasion and Metastasis , 2012, International journal of biological sciences.
[173] Kai Zhang,et al. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding , 2014, Nature Genetics.
[174] M. Lacroix-Triki,et al. RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor , 2013, Breast Cancer Research.
[175] S. Ichwan,et al. E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53. , 2003, Molecular cancer research : MCR.
[176] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[177] W. Shi,et al. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. , 2013, Blood.
[178] H. Esumi,et al. Induction of cell-cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family. , 2003, Biochemical and biophysical research communications.
[179] T. Marr,et al. Computational analysis of 3'-ends of ESTs shows four classes of alternative polyadenylation in human, mouse, and rat. , 2005, Genome research.
[180] C. Burge,et al. The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.
[181] Larissa Belov,et al. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias. , 2008, Leukemia research.
[182] Oliver Hofmann,et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. , 2009, Molecular cell.
[183] C. Redfern,et al. Overexpression of RARγ increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinide , 2006, Cell Death and Differentiation.
[184] Jun Chen,et al. The integral nuclear membrane protein nurim plays a role in the suppression of apoptosis. , 2012, Current molecular medicine.
[185] V. Haucke,et al. The oncogenic TBC domain protein USP6/TRE17 regulates cell migration and cytokinesis , 2012, Biology of the cell.
[186] C. Yee,et al. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation , 2002, Nature.
[187] H. Hermeking,et al. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc , 2004, Oncogene.
[188] Gang Rui,et al. Oncogenic Activity of Retinoic Acid Receptor γ Is Exhibited through Activation of the Akt/NF-κB and Wnt/β-Catenin Pathways in Cholangiocarcinoma , 2013, Molecular and Cellular Biology.
[189] Job Harms,et al. THE LANDSCAPE OF , 2010 .
[190] T. Ochiya,et al. Susceptibility of Snark‐deficient mice to azoxymethane‐induced colorectal tumorigenesis and the formation of aberrant crypt foci , 2008, Cancer science.
[191] B. Haddad,et al. Amplification of the BP1 homeobox gene in breast cancer. , 2008, Cancer genetics and cytogenetics.
[192] Mirko Cevec,et al. NMR structure of the let-7 miRNA interacting with the site LCS1 of lin-41 mRNA from Caenorhabditis elegans , 2010, Nucleic acids research.
[193] Xiwen Cheng,et al. G Protein Pathway Suppressor 2 (GPS2) Is a Transcriptional Corepressor Important for Estrogen Receptor α-mediated Transcriptional Regulation* , 2009, The Journal of Biological Chemistry.
[194] A. Weeraratna,et al. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes , 2006, BMC Immunology.
[195] T Takahashi,et al. Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach , 2007, Oncogene.
[196] M. Shepelev,et al. The RHOV gene is overexpressed in human non-small cell lung cancer. , 2013, Cancer genetics.
[197] Jaw-Yuan Wang,et al. EVI2B, ATP2A2, S100B, TM4SF3, and OLFM4 as potential prognostic markers for postoperative Taiwanese colorectal cancer patients. , 2012, DNA and cell biology.
[198] S. Bose,et al. Oncogenic Role of Engrailed-2 (En-2) in Prostate Cancer Cell Growth and Survival , 2008, Translational oncogenomics.
[199] Rameen Beroukhim,et al. An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB , 2010, Nature Medicine.
[200] Andreas Keller,et al. MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors , 2012, PloS one.
[201] Joshua J. Steffan,et al. The Transcription Factor SPDEF Suppresses Prostate Tumor Metastasis* , 2012, The Journal of Biological Chemistry.
[202] T. Lu,et al. Loss of USF transcriptional activity in breast cancer cell lines , 1999, Oncogene.
[203] Y. Jeng,et al. The stem cell E3‐ligase Lin‐41 promotes liver cancer progression through inhibition of microRNA‐mediated gene silencing , 2013, The Journal of pathology.
[204] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[205] P. Sharp,et al. Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.
[206] Zhiyuan Shen,et al. Genomic structure of the human BCCIP gene and its expression in cancer. , 2003, Gene.
[207] P. Ye,et al. Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma. , 2010, Cancer research.